Hepatocellular Carcinoma & Hypoxia: A Review

References (81)

1. 1 Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 [DOI]
2. 2 Management of Hepatocellular Carcinoma * [DOI]
3. 3 Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification [DOI]
4. 4 The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy [DOI]
5. 5 Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa [DOI]
6. 6 Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma [DOI]
7. 7 Hypoxia-Induced Angiogenesis: Good and Evil [DOI]
8. 8 Steatosis Accelerates the Progression of Liver Damage of Chronic Hepatitis C Patients and Correlates With Specific Hcv Genotype and Visceral Obesity [DOI]
9. 9 Liver fibrosis in overweight patients [DOI]
10. 10 Sustained proliferation in cancer: Mechanisms and novel therapeutic targets [DOI]
11. 11 Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study [DOI]
12. 12 Hypoxia-mediated drug resistance: Novel insights on the functional interaction of HIFs and cell death pathways [DOI]
13. 13 Focus on hepatocellular carcinoma [DOI]
14. 14 Pathogenesis of alcoholic liver disease: Role of oxidative metabolism [DOI]
15. 15 Performance status assessment in cancer patients. An inter-observer variability study [DOI]
16. 16 Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma [DOI]
17. 17 Dysregulation of growth factor signaling in human hepatocellular carcinoma [DOI]
18. 18 Performance status assessment in cancer patients [DOI]
19. 19 Treatment of Hepatocellular Carcinoma: A Systematic Review [DOI]
20. 20 Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection [DOI]
21. 21 Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection [DOI]
22. 22 Hyperbaric oxygen therapy and cancer—a review [DOI]
23. 23 The detoxification enzyme systems.
24. 24 The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma [DOI]
25. 25 Hypoxia: A Link between Fibrogenesis, Angiogenesis, and Carcinogenesis in Liver Disease [DOI]
26. 26 Extracellular acidity, a “reappreciated” trait of tumor environment driving malignancy: perspectives in diagnosis and therapy [DOI]
27. 27 Hypoxia-regulated target genes implicated in tumor metastasis [DOI]
28. 28 Bioreductive prodrugs as cancer therapeutics: targeting tumor hypoxia [DOI]
29. 29 The Role of Hypoxia Inducible Factor-1 in Hepatocellular Carcinoma [DOI]
30. 30 Quercetin Potentiates Doxorubicin Mediated Antitumor Effects against Liver Cancer through p53/Bcl-xl [DOI]
31. 31 Southern Europe as an example of interaction between various environmental factors: a systematic review of the epidemiologic evidence [DOI]
32. 32 Portal Vein Embolization for Hepatocellular Carcinoma [DOI]
33. 33 Clinical oxygen enhancement ratio of tumors in carbon ion radiotherapy: the influence of local oxygenation changes [DOI]
34. 34 Hypoxia-Mediated Metastasis [DOI]
35. 35 Weights of brain, heart, liver, kidneys, and spleen in healthy and apparently healthy adult Danish subjects [DOI]
36. 36 Impact of diabetes mellitus on outcome of HCC [DOI]
37. 37 Combination of Local Transcatheter Arterial Chemoembolization and Systemic Anti-angiogenic Therapy for Unresectable Hepatocellular Carcinoma [DOI]
38. 38 Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis [DOI]
39. 39 Contrast-enhanced doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis [DOI]
40. 40 Pyruvate dehydrogenase kinase expression and metabolic changes following dichloroacetate exposure in anoxic human colorectal cancer cells [DOI]
41. 41 Synergistic Inhibitory Effect of Hyperbaric Oxygen Combined with Sorafenib on Hepatoma Cells [DOI]
42. 42 Hypoxia Inducible Factor Pathways as Targets for Functional Foods [DOI]
43. 43 The Neonatal Liver, Part 1: Embryology, Anatomy, and Physiology [DOI]
44. 44 Liver Diseases : An Essential Guide for Nurses and Health Care Professionals
45. 45 Hypoxic regulation of metabolism offers new opportunities for anticancer therapy [DOI]
46. 46 Hypoxia-induced radioresistance is independent of hypoxia-inducible factor-1A in vitro [DOI]
47. 47 Sonographic appearances of small hepatic nodules without tumor stain on contrast-enhanced computed tomography and angiography [DOI]
48. 48 Imaging of hepatocellular carcinoma [DOI]
49. 49 Oxygen Tension Distribution in Head and Neck Carcinomas after Peroral Oxygen Therapy [DOI]
50. 50 Advances in Experimental Medicine and Biology [DOI]
51. 51 Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 [DOI]
52. 52 Mechanisms of HBV-induced hepatocellular carcinoma [DOI]
53. 53 Hypoxia and metabolic adaptation of cancer cells [DOI]
54. 54 Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer [DOI]
55. 55 Bioconjugated Manganese Dioxide Nanoparticles Enhance Chemotherapy Response by Priming Tumor-Associated Macrophages toward M1-like Phenotype and Attenuating Tumor Hypoxia [DOI]
56. 56 The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy [DOI]
57. 57 The impact of hypoxia and its modification of the outcome of radiotherapy [DOI]
58. 58 Sorafenib in Advanced Hepatocellular Carcinoma [DOI]
59. 59 Molecular targeting of hypoxia in radiotherapy [DOI]
60. 60 New advances in hepatocellular carcinoma [DOI]
61. 61 Silver nanoparticles inhibit the function of hypoxia-inducible factor-1 and target genes: insight into the cytotoxicity and antiangiogenesis [DOI]
62. 62 Hepatocellular carcinoma: Where are we? [DOI]
63. 63 Hybrid Manganese Dioxide Nanoparticles Potentiate Radiation Therapy by Modulating Tumor Hypoxia [DOI]
64. 64 Cancer: fundamentals behind pH targeting and the double-edged approach [DOI]
65. 65 Aflatoxin B1 induces persistent epigenomic effects in primary human hepatocytes associated with hepatocellular carcinoma [DOI]
66. 66 Vorinostat suppresses hypoxia signaling by modulating nuclear translocation of hypoxia inducible factor 1 alpha [DOI]
67. 67 PHD2: from hypoxia regulation to disease progression [DOI]
68. 68 Hepatocellular carcinoma and non-alcoholic steatohepatitis: The state of play [DOI]
69. 69 Liver transplantation for hepatocellular carcinoma beyond the Milan criteria: A review [DOI]
70. 70 Mechanisms through Which Hypoxia-Induced Caveolin-1 Drives Tumorigenesis and Metastasis in Hepatocellular Carcinoma [DOI]
71. 71 Phosphorylation of the PDH complex precedes HIF-1-mediated effects and PDK1 upregulation during the first hours of hypoxic treatment in HCC cells [DOI]
72. 72 The Effects of Severe Hypoxia on Glycolytic Flux and Enzyme Activity in a Model of Solid Tumors [DOI]
73. 73 Anticancer efficacy of the hypoxia‐activated prodrug evofosfamide (TH‐302) in osteolytic breast cancer murine models [DOI]
74. 74 Innovative surgical approaches for hepatocellular carcinoma [DOI]
75. 75 How Hepatitis C Virus Leads to Hepatocellular Carcinoma: A Network-Based Study [DOI]
76. 76 Molecular and functional evaluation of a novel HIF inhibitor, benzopyranyl 1,2,3-triazole compound [DOI]
77. 77 Radiotherapy in the multidisciplinary treatment of liver cancer: a survey on behalf of the Italian Association of Radiation Oncology [DOI]
78. 78 Proceedings of the National Academy of Sciences of the United States of America [DOI]
79. 79 Journal of Agricultural and Food Chemistry [DOI]
80. 80 International Journal of Nanomedicine [DOI]
81. 81 Journal of Gastroenterology and Hepatology [DOI]

Cited by 2

Showing 1 of 2 known citations — external sources report more than can currently be individually listed.

Related research

• Effects of Hydro-ethanolic Leaf Extract of Tithonia diversifolia on Parasitaemia Level, Serum Metabolites and Histopathology of Organs in Swiss Albino Mice Infected with Plasmodium berghei NK65 — shares topic coverage
• Common Findings in Ultrasound Examination of the Liver and Kidney in Sokoto Metropolis — shares topic coverage
• Liver Profile of Artemether-lumefantrine-tinidazole in Healthy and Parasitized Mice — shares topic coverage
• Sonographic Assessment of Maternal Portal Vein Diameter in Healthy Pregnancy in South-South Nigeria — shares topic coverage
• Quadruple Arterial Blood Supply to the Liver: A Rare Variation — shares topic coverage